{
  "id": "adv_mhgap#risk_safety_92a71e40",
  "content": "44. Machado S, Telles G, Magalhaes F, Teixeira D,\n021-99882-w).\nAmatriain-Fernández S, Budde H et al. Can\n37. van Dis EAM, van Veen SC, Hagenaars MA, Batelaan regular physical exercise be a treatment for\nNM, Bockting CLH, van den Heuvel RM et al. panic disorder? A systematic review. Expert Rev\nLong-term outcomes of cognitive behavioral Neurother. 2022;22(1):53–64 (https://doi.org/10.10\ntherapy for anxiety-related disorders: a systematic 80/14737175.2021.2005581).\nreview and meta-analysis. JAMA Psychiatry.\n45. WHO guidelines on physical activity and sedentary\n2020;77(3):265–73 (https://doi.org/10.1001/\nbehaviour. Geneva: World Health Organization;\njamapsychiatry.2019.3986).\n2020 (https://iris.who.int/handle/10665/336656).\n38. Papola D, Purgato M, Gastaldon C, Bovo C, van\n46. Breilmann J, Girlanda F, Guaiana G, Barbui C,\nOmmeren M, Barbui C et al. Psychological and\nCipriani A, Castellazzi M et al. Benzodiazepines\nsocial interventions for the prevention of mental\nversus placebo for panic disorder in adults.\ndisorders in people living in low- and middle-\nCochrane Database Syst Rev. 2019;(3):CD010677.\nincome countries affected by humanitarian crises.\nCochrane Database Syst Rev. 2020;(9):CD012417. 47. Shinfuku M, Kishimoto T, Uchida H, Suzuki T,\nMimura M, Kikuchi T. Effectiveness and safety\n39. Barkowski S, Schwartze D, Strauss B, Burlingame\nof long-term benzodiazepine use in anxiety\nGM, Rosendahl J. Efficacy of group psychotherapy",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "coping_skill",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety 44. Machado S, Telles G, Magalhaes F, Teixeira D,\n021-99882-w).\nAmatriain-Fernández S, Budde H et al. Can\n37. van Dis EAM, van Veen SC, Hagenaars MA, Batelaan regular physical exercise be a treatment for\nNM, Bockting CLH, van den Heuvel RM et al. panic disorder? A systematic review. Expert Rev\nLong-term outcomes of cognitive behavioral Neurother. 2022;22(1):53–64 (https://doi.org/10.10\ntherapy for anxiety-related disorders: a systematic 80/14737175.2021.2005581).\nreview and meta-analysis. JAMA Psychiatry.\n45. WHO guidelines on physical activity and sedentary\n2020;77(3):265–73 (https://doi.org/10.1001/\nbehaviour. Geneva: World Health Organization;\njamapsychiatry.2019.3986).\n2020 (https://iris.who.int/handle/10665/336656).\n38. Papola D, Purgato M, Gastaldon C, Bovo C, van\n46. Breilmann J, Girlanda F, Guaiana G, Barbui C,\nOmmeren M, Barbui C et al. Psychological and\nCipriani A, Castellazzi M et al. Benzodiazepines\nsocial interventions for the prevention of mental\nversus placebo for panic disorder in adults.\ndisorders in people living in low- and middle-\nCochrane Database Syst Rev. 2019;(3):CD010677.\nincome countries affected by humanitarian crises.\nCochrane Database Syst Rev. 2020;(9):CD012417. 47. Shinfuku M, Kishimoto T, Uchida H, Suzuki T,\nMimura M, Kikuchi T. Effectiveness and safety\n39. Barkowski S, Schwartze D, Strauss B, Burlingame\nof long-term benzodiazepine use in anxiety\nGM, Rosendahl J. Efficacy of group psychotherapy 44. machado s, telles g, magalhaes f, teixeira d,\n021-99882-w)."
}